India covid-19 patient India

Mankind Pharma gets approval to manufacture, market Covid drug 2-DG

Reading now: 433
www.livemint.com

Mankind Pharma has received the licence to manufacture and market oral 2-deoxy-D-glucose (2-DG) from Defence Research and Development Organisation (DRDO), the company said on Thursday.

The drug is used for the treatment of COVID-19. In a statement, the company said, 2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior.

The clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy's Laboratories.

It will manufacture the product at its facilities in Visakhapatnam and Himachal Pradesh, it added. The office of the Drugs Controller General of India (DCGI) on May 1 had permitted the emergency use of 2-DG as an adjunct

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA